Africa In Vitro Diagnostics Market by Product & Services, Technology (Immunoassay, PoC, Molecular Diagnostics, Coagulation), Application (Infectious Diseases, Diabetes, Oncology), Diagnostic Approach (Lab, OTC, PoC), Customer Type — Forecast to 2029
Africa In Vitro Diagnostics Market by Product & Services, Technology (Immunoassay, Point of Care, Molecular Diagnostics, Coagulation), Application (Infectious Diseases, Diabetes, Oncology), Diagnostic Approach (Lab, OTC, PoC), Customer Type — Forecast to 2029
The Africa IVD market is expected to grow at a CAGR of 4.8% from 2022 to 2029 to reach $1.78 billion by 2029
Following a detailed secondary and primary research and an in-depth analysis of the market scenario, the report provides the key drivers, restraints, challenges, and opportunities in the Africa IVD market.
The high prevalence of infectious diseases, the rising burden of chronic diseases, the rising initiatives to support the healthcare sector, and the growing awareness about the importance of early disease diagnosis are the major drivers for the Africa IVD market. However, poor healthcare facilities and infrastructure in African countries are the major challenges to the market’s growth.
Based on product category, in 2022, the reagents, assays, and kits segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is attributed to the frequent use of assays & kits in the detection of various chronic diseases coupled with the high burden of infectious diseases in African countries.
Based on technology, in 2022, the immunoassay segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is attributed to the advantages of immunoassays, such as simplicity, high accuracy standards, high throughput capability, and inherent specificity.
Based on application, in 2022, the infectious diseases segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is primarily attributed to the high prevalence of infectious diseases such as COVID-19, dengue, HIV, and Chagas disease in the region and the rising initiatives to boost testing capabilities.
Based on diagnostic approach, in 2022, the laboratory testing segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is attributed to the availability of several IVD tests and the higher accuracy offered by laboratory testing.
Based on customer type, in 2022, the hospital laboratories testing segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is attributed to the high demand for IVD diagnostics and the higher preference for hospitals as the primary center of care.
Based on geography, in 2022, South Africa is expected to account for the largest share of this market. The major share of this region is mainly attributed to the high burden of diseases, the rising geriatric population, the increasing initiatives to promote diagnostic testing, and continuous efforts to develop healthcare infrastructure and promote awareness.
The key companies operating in the Africa IVD market are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), bioM?rieux SA (France), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Siemens Healthineers AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Illumina, Inc. (U.S.), and Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China).
Scope of the Report:
Africa IVD Market, by Product Category
Africa IVD Market, by Application
Africa IVD Market, by Diagnostic Approach
Africa IVD Market, by Country
The Africa IVD market is expected to grow at a CAGR of 4.8% from 2022 to 2029 to reach $1.78 billion by 2029
Following a detailed secondary and primary research and an in-depth analysis of the market scenario, the report provides the key drivers, restraints, challenges, and opportunities in the Africa IVD market.
The high prevalence of infectious diseases, the rising burden of chronic diseases, the rising initiatives to support the healthcare sector, and the growing awareness about the importance of early disease diagnosis are the major drivers for the Africa IVD market. However, poor healthcare facilities and infrastructure in African countries are the major challenges to the market’s growth.
Based on product category, in 2022, the reagents, assays, and kits segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is attributed to the frequent use of assays & kits in the detection of various chronic diseases coupled with the high burden of infectious diseases in African countries.
Based on technology, in 2022, the immunoassay segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is attributed to the advantages of immunoassays, such as simplicity, high accuracy standards, high throughput capability, and inherent specificity.
Based on application, in 2022, the infectious diseases segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is primarily attributed to the high prevalence of infectious diseases such as COVID-19, dengue, HIV, and Chagas disease in the region and the rising initiatives to boost testing capabilities.
Based on diagnostic approach, in 2022, the laboratory testing segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is attributed to the availability of several IVD tests and the higher accuracy offered by laboratory testing.
Based on customer type, in 2022, the hospital laboratories testing segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is attributed to the high demand for IVD diagnostics and the higher preference for hospitals as the primary center of care.
Based on geography, in 2022, South Africa is expected to account for the largest share of this market. The major share of this region is mainly attributed to the high burden of diseases, the rising geriatric population, the increasing initiatives to promote diagnostic testing, and continuous efforts to develop healthcare infrastructure and promote awareness.
The key companies operating in the Africa IVD market are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), bioM?rieux SA (France), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Siemens Healthineers AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Illumina, Inc. (U.S.), and Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China).
Scope of the Report:
Africa IVD Market, by Product Category
- Reagents, Assays, and Kits
- Instruments
- Software & Services
- Immunoassay
- Whole Blood Glucose Monitoring
- Point-of-Care Diagnostics
- Clinical Chemistry
- Molecular Diagnostics
- Hematology
- Coagulation & Hemostasis
- Critical Care
- Urinalysis
- Other IVD Technologies
Africa IVD Market, by Application
- Infectious Diseases
- Diabetes
- Oncology
- Endocrinology
- Cardiology
- Other Applications
Africa IVD Market, by Diagnostic Approach
- Laboratory Testing
- Point-of-Care Testing
- OTC/Self-testing
- Hospital Labs
- Private Labs
- Home Care/Self Testing
- Government
- Other Customer Types
Africa IVD Market, by Country
- South Africa
- Egypt
- Nigeria
- Kenya
- Algeria
- Tanzania
- Morocco
- Tunisia
- Rest of Africa
1. INTRODUCTION
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.1.3. Growth Forecast
2.3.2. Market Share Analysis
2.4. Assumptions for the Study
2.5. Limitations for the Study
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Overview
4.2. Drivers
4.2.1. Government Initiatives Supporting Africa’s Healthcare Sector
4.2.2. Rising Prevalence of Communicable and Noncommunicable Diseases
4.2.3. Key Market Players’ Increasing Investments in Africa’s IVD Sector
4.3. Restraints
4.3.1. High Prices of IVD Products
4.4. Opportunities
4.4.1. Increasing Awareness About the Importance of Early Diagnosis
4.5. Challenges
4.5.1. Uneven Access to Healthcare
4.5.2. Shortage of Trained Healthcare Personnel
5. AFRICA IVD MARKET, BY PRODUCT CATEGORY
5.1. Introduction
5.2. Reagents, Assays, and Kits
5.3. Instruments
5.4. Software & Services
6. AFRICA IVD MARKET, BY TECHNOLOGY
6.1. Introduction
6.2. Immunoassay
6.3. Whole Blood Glucose Monitoring
6.4. Point-of-Care Diagnostics
6.5. Clinical Chemistry
6.6. Molecular Diagnostics
6.7. Hematology
6.8. Coagulation & Hemostasis
6.9. Critical Care
6.10. Urinalysis
6.11. Other IVD Technologies
7. AFRICA IVD MARKET, BY APPLICATION
7.1. Introduction
7.2. Infectious Diseases
7.3. Oncology
7.4. Diabetes
7.5. Endocrinology
7.6. Cardiology
7.7. Other Applications
8. AFRICA IVD MARKET, BY DIAGNOSTIC APPROACH
8.1. Introduction
8.2. Laboratory Testing
8.3. Point-of-Care Testing
8.4. OTC/Self-Testing
9. AFRICA IN VITRO DIAGNOSTICS MARKET, BY CUSTOMER TYPE
9.1. Introduction
9.2. Hospital Labs
9.3. Private Labs
9.4. Home Care/Self-Testing
9.5. Government
9.6. Other Customer Types
10. AFRICA IVD MARKET, BY GEOGRAPHY
10.1. Introduction
10.2. South Africa
10.3. Egypt
10.4. Nigeria
10.5. Kenya
10.6. Algeria
10.7. Tanzania
10.8. Morocco
10.9. Tunisia
10.10. Rest of Africa
11. COMPETITIVE LANDSCAPE
11.1. Introduction
11.2. Key Growth Strategies
11.3. Competitive Benchmarking
11.4. Market Share Analysis (2021)
11.4.1. F. Hoffmann-La Roche Ltd (Switzerland)
11.4.2. Abbott Laboratories (U.S.)
11.4.3. Danaher Corporation (U.S.)
12. COMPANY PROFILES (BUSINESS OVERVIEW, FINANCIAL OVERVIEW, SOLUTIONS PORTFOLIO, STRATEGIC DEVELOPMENTS)
12.1. Abbott Laboratories
12.2. Becton, Dickinson and Company
12.3. bioM?rieux SA
12.4. Danaher Corporation
12.5. F. Hoffmann-La Roche Ltd
12.6. QIAGEN N.V.
12.7. Siemens Healthineers AG (Subsidiary of Siemens AG)
12.8. Thermo Fisher Scientific Inc.
12.9. Bio-Rad Laboratories, Inc.
12.10. Illumina, Inc.
12.11. Shenzhen Mindray Bio-Medical Electronics Co., Ltd
13. APPENDIX
13.1. Questionnaire
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.1.3. Growth Forecast
2.3.2. Market Share Analysis
2.4. Assumptions for the Study
2.5. Limitations for the Study
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Overview
4.2. Drivers
4.2.1. Government Initiatives Supporting Africa’s Healthcare Sector
4.2.2. Rising Prevalence of Communicable and Noncommunicable Diseases
4.2.3. Key Market Players’ Increasing Investments in Africa’s IVD Sector
4.3. Restraints
4.3.1. High Prices of IVD Products
4.4. Opportunities
4.4.1. Increasing Awareness About the Importance of Early Diagnosis
4.5. Challenges
4.5.1. Uneven Access to Healthcare
4.5.2. Shortage of Trained Healthcare Personnel
5. AFRICA IVD MARKET, BY PRODUCT CATEGORY
5.1. Introduction
5.2. Reagents, Assays, and Kits
5.3. Instruments
5.4. Software & Services
6. AFRICA IVD MARKET, BY TECHNOLOGY
6.1. Introduction
6.2. Immunoassay
6.3. Whole Blood Glucose Monitoring
6.4. Point-of-Care Diagnostics
6.5. Clinical Chemistry
6.6. Molecular Diagnostics
6.7. Hematology
6.8. Coagulation & Hemostasis
6.9. Critical Care
6.10. Urinalysis
6.11. Other IVD Technologies
7. AFRICA IVD MARKET, BY APPLICATION
7.1. Introduction
7.2. Infectious Diseases
7.3. Oncology
7.4. Diabetes
7.5. Endocrinology
7.6. Cardiology
7.7. Other Applications
8. AFRICA IVD MARKET, BY DIAGNOSTIC APPROACH
8.1. Introduction
8.2. Laboratory Testing
8.3. Point-of-Care Testing
8.4. OTC/Self-Testing
9. AFRICA IN VITRO DIAGNOSTICS MARKET, BY CUSTOMER TYPE
9.1. Introduction
9.2. Hospital Labs
9.3. Private Labs
9.4. Home Care/Self-Testing
9.5. Government
9.6. Other Customer Types
10. AFRICA IVD MARKET, BY GEOGRAPHY
10.1. Introduction
10.2. South Africa
10.3. Egypt
10.4. Nigeria
10.5. Kenya
10.6. Algeria
10.7. Tanzania
10.8. Morocco
10.9. Tunisia
10.10. Rest of Africa
11. COMPETITIVE LANDSCAPE
11.1. Introduction
11.2. Key Growth Strategies
11.3. Competitive Benchmarking
11.4. Market Share Analysis (2021)
11.4.1. F. Hoffmann-La Roche Ltd (Switzerland)
11.4.2. Abbott Laboratories (U.S.)
11.4.3. Danaher Corporation (U.S.)
12. COMPANY PROFILES (BUSINESS OVERVIEW, FINANCIAL OVERVIEW, SOLUTIONS PORTFOLIO, STRATEGIC DEVELOPMENTS)
12.1. Abbott Laboratories
12.2. Becton, Dickinson and Company
12.3. bioM?rieux SA
12.4. Danaher Corporation
12.5. F. Hoffmann-La Roche Ltd
12.6. QIAGEN N.V.
12.7. Siemens Healthineers AG (Subsidiary of Siemens AG)
12.8. Thermo Fisher Scientific Inc.
12.9. Bio-Rad Laboratories, Inc.
12.10. Illumina, Inc.
12.11. Shenzhen Mindray Bio-Medical Electronics Co., Ltd
13. APPENDIX
13.1. Questionnaire
LIST OF TABLES
Table 1 Africa IVD Market Drivers: Impact Analysis (2022–2029)
Table 2 Africa: Rural Population as a Percentage of the Total Population, by Country (2021)
Table 3 Africa IVD Market Size, by Product Category, 2022–2029 (USD Million)
Table 4 Africa IVD Market Size for Reagents, Assays, and Kits, by Country/Region, 2022–2029 (USD Million)
Table 5 Africa IVD Market Size for Instruments, by Country/Region, 2022–2029 (USD Million)
Table 6 Africa IVD Market Size for Software & Services, by Country/Region, 2022–2029 (USD Million)
Table 7 Africa IVD Market, by Technology, 2020–2029 (USD Million)
Table 8 Africa IVD Market Size for Immunoassay, by Country/Region, 2020–2029 (USD Million)
Table 9 Africa IVD Market Size for Whole Blood Glucose Monitoring, by Country/Region, 2020-2029 (USD Million)
Table 10 Africa IVD Market Size for Point-of-Care Diagnostics, by Country/Region, 2020–2029 (USD Million)
Table 11 Africa IVD Market Size for Clinical Chemistry, by Country/Region, 2020–2029 (USD Million)
Table 12 Africa IVD Market Size for Molecular Diagnostics, by Country/Region, 2020–2029 (USD Million)
Table 13 Africa IVD Market Size for Hematology, by Country/Region, 2020–2029 (USD Million)
Table 14 Africa IVD Market Size for Coagulation and Hemostasis, by Country/Region, 2020–2029 (USD Million)
Table 15 Africa IVD Market Sze for Critical Care Diagnostics, by Country/Region, 2020–2029 (USD Million)
Table 16 Africa IVD Market Sze for Urinalysis, by Country/Region, 2020–2029 (USD Million)
Table 17 Africa IVD Market Sze for Other IVD Technologies, by Country/Region, 2020–2029 (USD Million)
Table 18 Africa IVD Market Size, by Application, 2020–2029 (USD Million)
Table 19 COVID-19 Cases & Mortalities in Africa (As of 15 November 2022)
Table 20 Africa IVD Market Size for Infectious Diseases, by Country/Region, 2022–2029 (USD Million)
Table 21 Africa: Cancer Burden, by Country, 2020
Table 22 Africa IVD Market Size for Oncology, by Country/Region, 2022–2029 (USD Million)
Table 23 Africa: Diabetes Cases, by Country (2021 Vs. 2030)
Table 24 Africa IVD Market Size for Diabetes, by Country/Region, 2022–2029 (USD Million)
Table 25 Africa IVD Market Size for Endocrinology, by Country/Region, 2022–2029 (USD Million)
Table 26 Africa IVD Market Size for Cardiology, by Country/Region, 2022–2029 (USD Million)
Table 27 Africa IVD Market Size for Other Applications, by Country/Region, 2022–2029 (USD Million)
Table 28 Africa IVD Market Size, by Diagnostic Approach, 2022–2029 (USD Million)
Table 29 Africa IVD Market Size for Laboratory Testing, by Country/Region, 2022–2029 (USD Million)
Table 30 Africa IVD Market Size for Point-of-Care Testing, by Country/Region, 2022–2029 (USD Million)
Table 31 Africa IVD Market Size for OTC/Self-Testing, by Country/Region, 2022–2029 (USD Million)
Table 32 Africa IVD Market Size, by Customer Type, 2020–2029 (USD Million)
Table 33 Africa IVD Market Size for Hospital Laboratories, by Country/Region, 2022–2029 (USD Million)
Table 34 Africa IVD Market Size for Private Laboratories, by Country/Region, 2022–2029 (USD Million)
Table 35 Africa IVD Market Size for Home Care/Self-Testing, by Country/Region, 2022–2029 (USD Million)
Table 36 Africa: Healthcare Spending, by Country/Region (2019)
Table 37 Africa IVD Market Size for Government, by Country/Region, 2022–2029 (USD Million)
Table 38 Africa IVD Market Size for Other Customer Types, by Country/Region, 2022–2029 (USD Million)
Table 39 Africa: HIV and AIDS Statistics (2020)
Table 40 Health Expenditure (% of GDP), 2018–2021
Table 41 Africa: Social and Economic Indicators, by Country
Table 42 Africa IVD Market, by Country/Region, 2020–2029 (USD Million)
Table 43 Africa IVD Market, by Product Category, 2020–2029 (USD Million)
Table 44 Africa IVD Market, by Technology, 2020–2029 (USD Million)
Table 45 Africa IVD Market, by Application, 2020–2029 (USD Million)
Table 46 Africa IVD Market, by Diagnostic Approach, 2020–2029 (USD Million)
Table 47 Africa IVD Market, by Customer Type, 2020–2029 (USD Million)
Table 48 South Africa: IVD Market, by Product Category, 2020–2029 (USD Million)
Table 49 South Africa: IVD Market, by Technology, 2020–2029 (USD Million)
Table 50 South Africa: IVD Market, by Application, 2020–2029 (USD Million)
Table 51 South Africa: IVD Market, by Diagnostic Approach, 2020–2029 (USD Million)
Table 52 South Africa: IVD Market, by Customer Type, 2020–2029 (USD Million)
Table 53 Egypt: IVD Market, by Product Category, 2020–2029 (USD Million)
Table 54 Egypt: IVD Market, by Technology, 2020–2029 (USD Million)
Table 55 Egypt: IVD Market, by Application, 2020–2029 (USD Million)
Table 56 Egypt: IVD Market, by Diagnostic Approach, 2020–2029 (USD Million)
Table 57 Egypt: IVD Market, by Customer Type, 2020–2029 (USD Million)
Table 58 Nigeria: IVD Market, by Product Category, 2020–2029 (USD Million)
Table 59 Nigeria: IVD Market, by Technology, 2020–2029 (USD Million)
Table 60 Nigeria: IVD Market, by Application, 2020–2029 (USD Million)
Table 61 Nigeria: IVD Market, by Diagnostic Approach, 2020–2029 (USD Million)
Table 62 Nigeria: IVD Market, by Customer Type, 2020–2029 (USD Million)
Table 63 Kenya: IVD Market, by Product Category, 2020–2029 (USD Million)
Table 64 Kenya: IVD Market, by Technology, 2020–2029 (USD Million)
Table 65 Kenya: IVD Market, by Application, 2020–2029 (USD Million)
Table 66 Kenya: IVD Market, by Diagnostic Approach, 2020–2029 (USD Million)
Table 67 Kenya: IVD Market, by Customer Type, 2020–2029 (USD Million)
Table 68 Algeria: IVD Market, by Product Category, 2020–2029 (USD Million)
Table 69 Algeria: IVD Market, by Technology, 2020–2029 (USD Million)
Table 70 Algeria: IVD Market, by Application, 2020–2029 (USD Million)
Table 71 Algeria: IVD Market, by Diagnostic Approach, 2020–2029 (USD Million)
Table 72 Algeria: IVD Market, by Customer Type, 2020–2029 (USD Million)
Table 73 Tanzania: IVD Market, by Product Category, 2020–2029 (USD Million)
Table 74 Tanzania: IVD Market, by Technology, 2020–2029 (USD Million)
Table 75 Tanzania: IVD Market, by Application, 2020–2029 (USD Million)
Table 76 Tanzania: IVD Market, by Diagnostic Approach, 2020–2029 (USD Million)
Table 77 Tanzania: IVD Market, by Customer Type, 2020–2029 (USD Million)
Table 78 Morocco: IVD Market, by Product Category, 2020–2029 (USD Million)
Table 79 Morocco: IVD Market, by Technology, 2020–2029 (USD Million)
Table 80 Morocco: IVD Market, by Application, 2020–2029 (USD Million)
Table 81 Morocco: IVD Market, by Diagnostic Approach, 2020–2029 (USD Million)
Table 82 Morocco: IVD Market, by Customer Type, 2020–2029 (USD Million)
Table 83 Tunisia: IVD Market, by Product Category, 2020–2029 (USD Million)
Table 84 Tunisia: IVD Market, by Technology, 2020–2029 (USD Million)
Table 85 Tunisia: IVD Market, by Application, 2020–2029 (USD Million)
Table 86 Tunisia: IVD Market, by Diagnostic Approach, 2020–2029 (USD Million)
Table 87 Tunisia: IVD Market, by Customer Type, 2020–2029 (USD Million)
Table 88 Prevalence of Diseases in The Rest of Africa Region
Table 89 Rest of Africa: IVD Market, by Product Category, 2020–2029 (USD Million)
Table 90 Rest of Africa: IVD Market, by Technology, 2020–2029 (USD Million)
Table 91 Rest of Africa: IVD Market, by Application, 2020–2029 (USD Million)
Table 92 Rest of Africa: IVD Market, by Diagnostic Approach, 2020–2029 (USD Million)
Table 93 Rest of Africa: IVD Market, by Customer Type, 2020–2029 (USD Million)
Table 94 Recent Developments, by Company, 2019–2022
Table 95 Abbott Laboratories in Africa
Table 96 Becton, Dickinson, and Company (BD): Subsidiaries in Africa
Table 97 bioM?rieux SA in Africa
Table 98 Company Subsidiaries and Associates in Africa
Table 99 Siemens Healthineers AG in Africa
Table 1 Africa IVD Market Drivers: Impact Analysis (2022–2029)
Table 2 Africa: Rural Population as a Percentage of the Total Population, by Country (2021)
Table 3 Africa IVD Market Size, by Product Category, 2022–2029 (USD Million)
Table 4 Africa IVD Market Size for Reagents, Assays, and Kits, by Country/Region, 2022–2029 (USD Million)
Table 5 Africa IVD Market Size for Instruments, by Country/Region, 2022–2029 (USD Million)
Table 6 Africa IVD Market Size for Software & Services, by Country/Region, 2022–2029 (USD Million)
Table 7 Africa IVD Market, by Technology, 2020–2029 (USD Million)
Table 8 Africa IVD Market Size for Immunoassay, by Country/Region, 2020–2029 (USD Million)
Table 9 Africa IVD Market Size for Whole Blood Glucose Monitoring, by Country/Region, 2020-2029 (USD Million)
Table 10 Africa IVD Market Size for Point-of-Care Diagnostics, by Country/Region, 2020–2029 (USD Million)
Table 11 Africa IVD Market Size for Clinical Chemistry, by Country/Region, 2020–2029 (USD Million)
Table 12 Africa IVD Market Size for Molecular Diagnostics, by Country/Region, 2020–2029 (USD Million)
Table 13 Africa IVD Market Size for Hematology, by Country/Region, 2020–2029 (USD Million)
Table 14 Africa IVD Market Size for Coagulation and Hemostasis, by Country/Region, 2020–2029 (USD Million)
Table 15 Africa IVD Market Sze for Critical Care Diagnostics, by Country/Region, 2020–2029 (USD Million)
Table 16 Africa IVD Market Sze for Urinalysis, by Country/Region, 2020–2029 (USD Million)
Table 17 Africa IVD Market Sze for Other IVD Technologies, by Country/Region, 2020–2029 (USD Million)
Table 18 Africa IVD Market Size, by Application, 2020–2029 (USD Million)
Table 19 COVID-19 Cases & Mortalities in Africa (As of 15 November 2022)
Table 20 Africa IVD Market Size for Infectious Diseases, by Country/Region, 2022–2029 (USD Million)
Table 21 Africa: Cancer Burden, by Country, 2020
Table 22 Africa IVD Market Size for Oncology, by Country/Region, 2022–2029 (USD Million)
Table 23 Africa: Diabetes Cases, by Country (2021 Vs. 2030)
Table 24 Africa IVD Market Size for Diabetes, by Country/Region, 2022–2029 (USD Million)
Table 25 Africa IVD Market Size for Endocrinology, by Country/Region, 2022–2029 (USD Million)
Table 26 Africa IVD Market Size for Cardiology, by Country/Region, 2022–2029 (USD Million)
Table 27 Africa IVD Market Size for Other Applications, by Country/Region, 2022–2029 (USD Million)
Table 28 Africa IVD Market Size, by Diagnostic Approach, 2022–2029 (USD Million)
Table 29 Africa IVD Market Size for Laboratory Testing, by Country/Region, 2022–2029 (USD Million)
Table 30 Africa IVD Market Size for Point-of-Care Testing, by Country/Region, 2022–2029 (USD Million)
Table 31 Africa IVD Market Size for OTC/Self-Testing, by Country/Region, 2022–2029 (USD Million)
Table 32 Africa IVD Market Size, by Customer Type, 2020–2029 (USD Million)
Table 33 Africa IVD Market Size for Hospital Laboratories, by Country/Region, 2022–2029 (USD Million)
Table 34 Africa IVD Market Size for Private Laboratories, by Country/Region, 2022–2029 (USD Million)
Table 35 Africa IVD Market Size for Home Care/Self-Testing, by Country/Region, 2022–2029 (USD Million)
Table 36 Africa: Healthcare Spending, by Country/Region (2019)
Table 37 Africa IVD Market Size for Government, by Country/Region, 2022–2029 (USD Million)
Table 38 Africa IVD Market Size for Other Customer Types, by Country/Region, 2022–2029 (USD Million)
Table 39 Africa: HIV and AIDS Statistics (2020)
Table 40 Health Expenditure (% of GDP), 2018–2021
Table 41 Africa: Social and Economic Indicators, by Country
Table 42 Africa IVD Market, by Country/Region, 2020–2029 (USD Million)
Table 43 Africa IVD Market, by Product Category, 2020–2029 (USD Million)
Table 44 Africa IVD Market, by Technology, 2020–2029 (USD Million)
Table 45 Africa IVD Market, by Application, 2020–2029 (USD Million)
Table 46 Africa IVD Market, by Diagnostic Approach, 2020–2029 (USD Million)
Table 47 Africa IVD Market, by Customer Type, 2020–2029 (USD Million)
Table 48 South Africa: IVD Market, by Product Category, 2020–2029 (USD Million)
Table 49 South Africa: IVD Market, by Technology, 2020–2029 (USD Million)
Table 50 South Africa: IVD Market, by Application, 2020–2029 (USD Million)
Table 51 South Africa: IVD Market, by Diagnostic Approach, 2020–2029 (USD Million)
Table 52 South Africa: IVD Market, by Customer Type, 2020–2029 (USD Million)
Table 53 Egypt: IVD Market, by Product Category, 2020–2029 (USD Million)
Table 54 Egypt: IVD Market, by Technology, 2020–2029 (USD Million)
Table 55 Egypt: IVD Market, by Application, 2020–2029 (USD Million)
Table 56 Egypt: IVD Market, by Diagnostic Approach, 2020–2029 (USD Million)
Table 57 Egypt: IVD Market, by Customer Type, 2020–2029 (USD Million)
Table 58 Nigeria: IVD Market, by Product Category, 2020–2029 (USD Million)
Table 59 Nigeria: IVD Market, by Technology, 2020–2029 (USD Million)
Table 60 Nigeria: IVD Market, by Application, 2020–2029 (USD Million)
Table 61 Nigeria: IVD Market, by Diagnostic Approach, 2020–2029 (USD Million)
Table 62 Nigeria: IVD Market, by Customer Type, 2020–2029 (USD Million)
Table 63 Kenya: IVD Market, by Product Category, 2020–2029 (USD Million)
Table 64 Kenya: IVD Market, by Technology, 2020–2029 (USD Million)
Table 65 Kenya: IVD Market, by Application, 2020–2029 (USD Million)
Table 66 Kenya: IVD Market, by Diagnostic Approach, 2020–2029 (USD Million)
Table 67 Kenya: IVD Market, by Customer Type, 2020–2029 (USD Million)
Table 68 Algeria: IVD Market, by Product Category, 2020–2029 (USD Million)
Table 69 Algeria: IVD Market, by Technology, 2020–2029 (USD Million)
Table 70 Algeria: IVD Market, by Application, 2020–2029 (USD Million)
Table 71 Algeria: IVD Market, by Diagnostic Approach, 2020–2029 (USD Million)
Table 72 Algeria: IVD Market, by Customer Type, 2020–2029 (USD Million)
Table 73 Tanzania: IVD Market, by Product Category, 2020–2029 (USD Million)
Table 74 Tanzania: IVD Market, by Technology, 2020–2029 (USD Million)
Table 75 Tanzania: IVD Market, by Application, 2020–2029 (USD Million)
Table 76 Tanzania: IVD Market, by Diagnostic Approach, 2020–2029 (USD Million)
Table 77 Tanzania: IVD Market, by Customer Type, 2020–2029 (USD Million)
Table 78 Morocco: IVD Market, by Product Category, 2020–2029 (USD Million)
Table 79 Morocco: IVD Market, by Technology, 2020–2029 (USD Million)
Table 80 Morocco: IVD Market, by Application, 2020–2029 (USD Million)
Table 81 Morocco: IVD Market, by Diagnostic Approach, 2020–2029 (USD Million)
Table 82 Morocco: IVD Market, by Customer Type, 2020–2029 (USD Million)
Table 83 Tunisia: IVD Market, by Product Category, 2020–2029 (USD Million)
Table 84 Tunisia: IVD Market, by Technology, 2020–2029 (USD Million)
Table 85 Tunisia: IVD Market, by Application, 2020–2029 (USD Million)
Table 86 Tunisia: IVD Market, by Diagnostic Approach, 2020–2029 (USD Million)
Table 87 Tunisia: IVD Market, by Customer Type, 2020–2029 (USD Million)
Table 88 Prevalence of Diseases in The Rest of Africa Region
Table 89 Rest of Africa: IVD Market, by Product Category, 2020–2029 (USD Million)
Table 90 Rest of Africa: IVD Market, by Technology, 2020–2029 (USD Million)
Table 91 Rest of Africa: IVD Market, by Application, 2020–2029 (USD Million)
Table 92 Rest of Africa: IVD Market, by Diagnostic Approach, 2020–2029 (USD Million)
Table 93 Rest of Africa: IVD Market, by Customer Type, 2020–2029 (USD Million)
Table 94 Recent Developments, by Company, 2019–2022
Table 95 Abbott Laboratories in Africa
Table 96 Becton, Dickinson, and Company (BD): Subsidiaries in Africa
Table 97 bioM?rieux SA in Africa
Table 98 Company Subsidiaries and Associates in Africa
Table 99 Siemens Healthineers AG in Africa
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Africa IVD Market, by Product Category, 2022 Vs. 2029 (USD Million)
Figure 8 Africa IVD Market, by Technology, 2022 Vs. 2029 (USD Million)
Figure 9 Africa IVD Market, by Application, 2022 Vs. 2029 (USD Million)
Figure 10 Africa IVD Market, by Diagnostic Approach, 2022 Vs. 2029 (USD Million)
Figure 11 Africa IVD Market, by Customer Type, 2022 Vs. 2029 (USD Million)
Figure 12 Africa IVD Market, by Geography, 2022 Vs. 2029 (USD Million)
Figure 13 Market Dynamics
Figure 14 Africa IVD Market Size, by Product Category, 2022 Vs. 2029 (USD Million)
Figure 15 Africa IVD Market, by Technology, 2022 Vs. 2029 (USD Million)
Figure 16 Adult Population (20–79 Years) with Diabetes in African Countries (Millions)
Figure 17 Africa IVD Market Size, by Application, 2022 Vs. 2029 (USD Million)
Figure 18 Number of HIV Cases Vs. HIV/AIDS Deaths in African Countries (2020)
Figure 19 Africa IVD Market Size, by Diagnostic Approach, 2022 Vs. 2029 (USD Million)
Figure 20 Africa in Vitro Diagnostics Market Size, by Customer Type, 2022 Vs. 2029 (USD Million)
Figure 21 Africa: Number of People (Aged 20–79 Years) with Diabetes (in Millions), 2021–2045
Figure 22 Africa IVD Market, by Snapshot, 20222–2029 (USD Million)
Figure 23 South Africa: Number of People (All Ages) Living with HIV (2010–2020)
Figure 24 South Africa: Number of People with Diabetes (in Thousands), 2000–2045
Figure 25 Nigeria: Number of PMI-Supported Health Facilities (2016–2020)
Figure 26 Algeria: Population Aged 65 and Above (2015–2021)
Figure 27 Algeria: People Aged 20-79 Years who have Diabetes (2011–2045) (in Thousands)
Figure 28 Tanzania: Number of People with HIV (2010–2020)
Figure 29 Tanzania: Number of Adults (20–79 Years) with Diabetes (2011–2021)
Figure 30 Morocco: Number of New Cancer Cases: 2020-2030
Figure 31 Share of People Living in Urban Areas: 2015–2020
Figure 32 Public Expenditure on Healthcare as Percent of Total Healthcare Expenditure: 2015 -2019
Figure 33 Key Growth Strategies Adopted by Leading Players (2019–2022)
Figure 34 Africa IVD Market: Competitive Benchmarking
Figure 35 Market Share Analysis: Africa IVD Industry (2021)
Figure 36 Abbott Laboratories: Financial Overview (2019–2021)
Figure 37 Becton, Dickinson, and Company: Financial Overview (2019–2021)
Figure 38 bioM?rieux SA: Financial Overview, (2019–2021)
Figure 39 Danaher Corporation: Financial Overview (2019–2021)
Figure 40 F. Hoffman-La Roche Ltd.: Financial Overview (2019–2021)
Figure 41 QIAGEN N.V.: Financial Overview (2019–2021)
Figure 42 Siemens Healthineers AG: Financial Overview (2019–2021)
Figure 43 Thermo Fisher Scientific Inc.: Financial Overview (2019–2021)
Figure 44 Bio-Rad Laboratories: Financial Overview (2019–2021)
Figure 45 Illumina, Inc.: Financial Overview (2019–2021)
Figure 46 Shenzhen Mindray Bio-Medical Electronics Co., Ltd: Financial Overview (2019–2021)
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Africa IVD Market, by Product Category, 2022 Vs. 2029 (USD Million)
Figure 8 Africa IVD Market, by Technology, 2022 Vs. 2029 (USD Million)
Figure 9 Africa IVD Market, by Application, 2022 Vs. 2029 (USD Million)
Figure 10 Africa IVD Market, by Diagnostic Approach, 2022 Vs. 2029 (USD Million)
Figure 11 Africa IVD Market, by Customer Type, 2022 Vs. 2029 (USD Million)
Figure 12 Africa IVD Market, by Geography, 2022 Vs. 2029 (USD Million)
Figure 13 Market Dynamics
Figure 14 Africa IVD Market Size, by Product Category, 2022 Vs. 2029 (USD Million)
Figure 15 Africa IVD Market, by Technology, 2022 Vs. 2029 (USD Million)
Figure 16 Adult Population (20–79 Years) with Diabetes in African Countries (Millions)
Figure 17 Africa IVD Market Size, by Application, 2022 Vs. 2029 (USD Million)
Figure 18 Number of HIV Cases Vs. HIV/AIDS Deaths in African Countries (2020)
Figure 19 Africa IVD Market Size, by Diagnostic Approach, 2022 Vs. 2029 (USD Million)
Figure 20 Africa in Vitro Diagnostics Market Size, by Customer Type, 2022 Vs. 2029 (USD Million)
Figure 21 Africa: Number of People (Aged 20–79 Years) with Diabetes (in Millions), 2021–2045
Figure 22 Africa IVD Market, by Snapshot, 20222–2029 (USD Million)
Figure 23 South Africa: Number of People (All Ages) Living with HIV (2010–2020)
Figure 24 South Africa: Number of People with Diabetes (in Thousands), 2000–2045
Figure 25 Nigeria: Number of PMI-Supported Health Facilities (2016–2020)
Figure 26 Algeria: Population Aged 65 and Above (2015–2021)
Figure 27 Algeria: People Aged 20-79 Years who have Diabetes (2011–2045) (in Thousands)
Figure 28 Tanzania: Number of People with HIV (2010–2020)
Figure 29 Tanzania: Number of Adults (20–79 Years) with Diabetes (2011–2021)
Figure 30 Morocco: Number of New Cancer Cases: 2020-2030
Figure 31 Share of People Living in Urban Areas: 2015–2020
Figure 32 Public Expenditure on Healthcare as Percent of Total Healthcare Expenditure: 2015 -2019
Figure 33 Key Growth Strategies Adopted by Leading Players (2019–2022)
Figure 34 Africa IVD Market: Competitive Benchmarking
Figure 35 Market Share Analysis: Africa IVD Industry (2021)
Figure 36 Abbott Laboratories: Financial Overview (2019–2021)
Figure 37 Becton, Dickinson, and Company: Financial Overview (2019–2021)
Figure 38 bioM?rieux SA: Financial Overview, (2019–2021)
Figure 39 Danaher Corporation: Financial Overview (2019–2021)
Figure 40 F. Hoffman-La Roche Ltd.: Financial Overview (2019–2021)
Figure 41 QIAGEN N.V.: Financial Overview (2019–2021)
Figure 42 Siemens Healthineers AG: Financial Overview (2019–2021)
Figure 43 Thermo Fisher Scientific Inc.: Financial Overview (2019–2021)
Figure 44 Bio-Rad Laboratories: Financial Overview (2019–2021)
Figure 45 Illumina, Inc.: Financial Overview (2019–2021)
Figure 46 Shenzhen Mindray Bio-Medical Electronics Co., Ltd: Financial Overview (2019–2021)
